- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06342206
The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
March 27, 2025 updated by: China Medical University Hospital
Attending Physician, Department of Chinese Medicine
Cerebral infarction is the second cause of death and the third cause of disability.
More than 13.7 million patients worldwide are diagnosed with stroke every year, and the number of deaths is 5.5 million, of which ischemic stroke is the major type, accounting for 87%.
Sequelae of stroke are problems that require long-term medical care.
If we can intervene and assist with Traditional Chinese Medicine (TCM) at early stage, it will be a great boon for patients.
In clinical practice, TCM collects data as the basis for diagnosis through the four diagnostic methods-look, listen, question, and feel the pulse.
Among these, tongue diagnosis and pulse diagnosis belong to the categories of look and feel the pulse.
At present, the objective examination instruments of TCM developed are mainly tongue diagnostic instruments and pulse diagnostic instruments.
Therefore, we hope to utilize tongue and pulse diagnoses as the main reference to analyze the changes in ischemic stroke stages.
The data of this study are collected from China Medical University Hospital and YuanRung Hospital-for further statistical analysis.
Ischemic stroke patients (ICD-10: I63) who were hospitalized within 1 week from the date of diagnosis were eligible to join this research project.
Tongue and pulse examinations were collected once per week within 1 month.
A total of 4 tongue-pulse examinations were collected in each case, which were categorized into acute stage (24 hours to 1 week), subacute stage (1 to 3 weeks) and chronic stage (more than 3 weeks).
[30] This research is to study the changes of tongue and pulse diagnoses in acute, subacute and chronic stages among ischemic patients who receive TCM diagnosis and treatment.
Through utilizing objective evaluation of Chinese and Western medical examination instruments, we hope to establish clear diagnostic standards for TCM syndrome types, so as to evaluate the efficacy of clinical diagnosis and treatment.
The goal is to improve the quality of TCM care and to provide Chinese and Western integrated treatment for stroke patients in the future.
This research can also serve as a reference for related TCM research and development.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lun-Chien Lo, profession
- Phone Number: 3300 886-04-22053366
- Email: cmulclo@gmail.com
Study Contact Backup
- Name: Yung-Sheng Huang, research assistant
- Phone Number: 886-0963239803
- Email: sefiloscatdog@gmail.com
Study Locations
-
-
-
Changhua, Taiwan, 510
- Recruiting
- YuanRung Hospital
-
Contact:
- LI-CHI TSAI
- Phone Number: 0919688481
-
Contact:
- YEN-HUA YANG
- Phone Number: 0912587467
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
stroke patients in acute phase within 1 week will be included, and continues to collect their data in 2~3 Weeks and 4 week.
Description
Inclusion Criteria:
- Patients older than 40 years of age, who acted in concert with the complete examination and answered the questionnaire.
- Participants were diagnosed as ischemic stroke (ICD-10:I63) by neurologist, and were approved by head CT or MRI examination.
- Those with a stable vital sign after being examined by an internal medicine specialist
- Those who experience a cerebral vascular accident within 10 days of the consultation
- Signing the agreement document to join the research program
Exclusion Criteria:
- Those with an unstable vital sign
- Patients who were unable to protrude their tongue or the protruding length was insufficient
- Those at risk of jaw dislocation
- Those with an arteriovenous shunt or fistula
- Those who experience seizures
- Those with poor cognition and communication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences between tongue diagnosis and pulse diagnosis in acute and chronic stroke patients
Time Frame: Beginning September 2022 through October 2024
|
To compare the differences between tongue and pulse diagnosis in acute, subacute and chronic phases of stroke patients using statistical methods.
|
Beginning September 2022 through October 2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 8, 2022
Primary Completion (Actual)
September 7, 2024
Study Completion (Estimated)
March 27, 2025
Study Registration Dates
First Submitted
March 26, 2024
First Submitted That Met QC Criteria
March 26, 2024
First Posted (Actual)
April 2, 2024
Study Record Updates
Last Update Posted (Actual)
April 2, 2025
Last Update Submitted That Met QC Criteria
March 27, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMUH111-REC2-144
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke, Ischemic
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingStroke | Stroke Gait Rehabilitation | Stroke Ischemic | Balance Deficits | Stroke (CVA) or Transient Ischemic AttackUnited States
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Jagiellonian UniversityCompletedStroke, Ischemic | Subacute StrokePoland
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan